Mrv2304 05182315532D 17 18 0 0 1 0 999 V2000 0.0000 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3819 -1.7224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1270 -2.5070 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.3020 -2.5070 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.1830 -3.1745 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0470 -1.7224 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.7376 -1.4675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6119 -3.1745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.4324 -3.0882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9173 -3.7557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5817 -4.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0667 -5.1768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7613 -4.5956 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2763 -3.9282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4559 -4.0144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 3 2 1 1 0 0 0 3 4 1 0 0 0 0 5 4 1 0 0 0 0 6 5 1 0 0 0 0 6 7 1 6 0 0 0 6 8 1 0 0 0 0 8 3 1 0 0 0 0 8 9 1 6 0 0 0 5 10 1 1 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 13 15 1 0 0 0 0 15 16 1 0 0 0 0 10 16 1 0 0 0 0 16 17 2 0 0 0 0 M END > DB17822 > drugbank > OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1CCC(=O)NC1=O > InChI=1S/C9H14N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4,6-8,12,14-15H,1-3H2,(H,10,13,16)/t4-,6+,7-,8-/m1/s1 > ZPTBLXKRQACLCR-XVFCMESISA-N > C9H14N2O6 > 246.219 > 246.085186179 > 6 > 31 > 0.6929771632485608 > 22.248443134150733 > 1 > 4 > 0 > 0 > 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione > -2.773158873 > 0 > 0 > 2 > 0 > 119.32999999999998 > 52.3418 > 2 > 1 > dihydrouridine > 0 > DB17822 > investigational > Dihydrouridine > 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione; 2,4(1h,3h)-pyrimidinedione, dihydro-1-.beta.-d-ribofuranosyl-; 5,6-dihydrouridine; Hydrouracil, 1-.beta.-d-ribofuranosyl-; Uridine, 5,6-dihydro- $$$$